(BUD) Anheuser Busch Inbev - Ratings and Ratios
Beer, Spirits, Beverages, Budweiser, Corona Extra
BUD EPS (Earnings per Share)
BUD Revenue
Description: BUD Anheuser Busch Inbev
Anheuser-Busch InBev SA/NV is a global brewing company with a diverse portfolio of approximately 500 beer brands, including well-known names like Budweiser, Corona Extra, and Stella Artois, as well as spirits-based ready-to-drink and non-alcohol beverages. The companys extensive brand portfolio is a key strength, allowing it to cater to different markets and consumer preferences.
From a financial perspective, Anheuser-Busch InBev SA/NV has a market capitalization of $135.23 billion, indicating a large-cap stock with significant market presence. The companys price-to-earnings (P/E) ratio is 20.39, slightly higher than its forward P/E of 18.87, suggesting moderate growth expectations. The return on equity (RoE) of 8.16% indicates a relatively stable return for shareholders.
To further analyze the companys performance, we can look at additional key performance indicators (KPIs) such as revenue growth, dividend yield, and debt-to-equity ratio. Anheuser-Busch InBev SA/NV has a history of paying consistent dividends, with a dividend yield of around 2-3% in recent years. The companys revenue growth has been driven by its global presence and brand portfolio, although it has faced challenges in certain markets due to changing consumer preferences and competition.
From a competitive perspective, Anheuser-Busch InBev SA/NV operates in a highly competitive industry with other major players like Molson Coors and Heineken. The companys large scale and diversified brand portfolio provide a competitive advantage, but it must continue to innovate and adapt to changing consumer trends to maintain its market position.
BUD Stock Overview
| Market Cap in USD | 122,987m |
| Sub-Industry | Brewers |
| IPO / Inception | 2009-07-01 |
BUD Stock Ratings
| Growth Rating | 20.4% |
| Fundamental | 57.2% |
| Dividend Rating | 57.6% |
| Return 12m vs S&P 500 | -12.0% |
| Analyst Rating | 4.15 of 5 |
BUD Dividends
| Dividend Yield 12m | 1.81% |
| Yield on Cost 5y | 2.06% |
| Annual Growth 5y | 9.19% |
| Payout Consistency | 89.8% |
| Payout Ratio | 30.9% |
BUD Growth Ratios
| Growth Correlation 3m | -85.8% |
| Growth Correlation 12m | 42.9% |
| Growth Correlation 5y | 11.4% |
| CAGR 5y | 2.72% |
| CAGR/Max DD 5y | 0.06 |
| Sharpe Ratio 12m | 0.45 |
| Alpha | -4.51 |
| Beta | 0.249 |
| Volatility | 22.24% |
| Current Volume | 1914.7k |
| Average Volume 20d | 2112.4k |
| Stop Loss | 60.7 (-3.1%) |
| Signal | -1.49 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (7.12b TTM) > 0 and > 6% of Revenue (6% = 3.51b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 0.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -20.15% (prev -15.92%; Δ -4.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 15.20b > Net Income 7.12b (YES >=105%, WARN >=100%) |
| Net Debt (68.52b) to EBITDA (8.79b) ratio: 7.80 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.64 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.99b) change vs 12m ago -2.40% (target <= -2.0% for YES) |
| Gross Margin 55.70% (prev 43.38%; Δ 12.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 27.75% (prev 28.44%; Δ -0.69pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.46 (EBITDA TTM 8.79b / Interest Expense TTM 3.15b) >= 6 (WARN >= 3) |
Altman Z'' 1.21
| (A) -0.06 = (Total Current Assets 21.21b - Total Current Liabilities 33.01b) / Total Assets 211.11b |
| (B) 0.23 = Retained Earnings (Balance) 47.64b / Total Assets 211.11b |
| (C) 0.04 = EBIT TTM 7.76b / Avg Total Assets 210.91b |
| (D) 0.56 = Book Value of Equity 67.21b / Total Liabilities 119.69b |
| Total Rating: 1.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.17
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 6.15% = 3.08 |
| 3. FCF Margin 19.93% = 4.98 |
| 4. Debt/Equity 0.92 = 2.10 |
| 5. Debt/Ebitda 8.40 = -2.50 |
| 6. ROIC - WACC -1.02% = -1.27 |
| 7. RoE 8.45% = 0.70 |
| 8. Rev. Trend -17.00% = -0.85 |
| 9. Rev. CAGR -0.21% = -0.04 |
| 10. EPS Trend 13.72% = 0.34 |
| 11. EPS CAGR 6.21% = 0.62 |
What is the price of BUD shares?
Over the past week, the price has changed by -0.67%, over one month by -5.59%, over three months by -10.22% and over the past year by +3.58%.
Is Anheuser Busch Inbev a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BUD is around 59.67 USD . This means that BUD is currently overvalued and has a potential downside of -4.74%.
Is BUD a buy, sell or hold?
- Strong Buy: 5
- Buy: 5
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BUD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.6 | 23.9% |
| Analysts Target Price | 77.6 | 23.9% |
| ValueRay Target Price | 64.2 | 2.5% |
Last update: 2025-08-28 04:34
BUD Fundamental Data Overview
CCE Cash And Equivalents = 7.27b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 17.9229
P/E Forward = 17.1527
P/S = 2.1016
P/B = 1.5184
P/EG = 1.4386
Beta = 0.867
Revenue TTM = 58.52b USD
EBIT TTM = 7.76b USD
EBITDA TTM = 8.79b USD
Long Term Debt = 70.23b USD (from longTermDebt, last quarter)
Short Term Debt = 3.60b USD (from shortTermDebt, last quarter)
Debt = 73.83b USD (Calculated: Short Term 3.60b + Long Term 70.23b)
Net Debt = 68.52b USD (from netDebt column, last quarter)
Enterprise Value = 189.55b USD (122.99b + Debt 73.83b - CCE 7.27b)
Interest Coverage Ratio = 2.46 (Ebit TTM 7.76b / Interest Expense TTM 3.15b)
FCF Yield = 6.15% (FCF TTM 11.66b / Enterprise Value 189.55b)
FCF Margin = 19.93% (FCF TTM 11.66b / Revenue TTM 58.52b)
Net Margin = 12.16% (Net Income TTM 7.12b / Revenue TTM 58.52b)
Gross Margin = 55.70% ((Revenue TTM 58.52b - Cost of Revenue TTM 25.93b) / Revenue TTM)
Tobins Q-Ratio = 2.82 (Enterprise Value 189.55b / Book Value Of Equity 67.21b)
Interest Expense / Debt = 1.11% (Interest Expense 818.0m / Debt 73.83b)
Taxrate = 29.83% (from yearly Income Tax Expense: 3.15b / 10.57b)
NOPAT = 5.44b (EBIT 7.76b * (1 - 29.83%))
Current Ratio = 0.64 (Total Current Assets 21.21b / Total Current Liabilities 33.01b)
Debt / Equity = 0.92 (Debt 73.83b / last Quarter total Stockholder Equity 80.67b)
Debt / EBITDA = 8.40 (Net Debt 68.52b / EBITDA 8.79b)
Debt / FCF = 6.33 (Debt 73.83b / FCF TTM 11.66b)
Total Stockholder Equity = 84.21b (last 4 quarters mean)
RoA = 3.37% (Net Income 7.12b, Total Assets 211.11b )
RoE = 8.45% (Net Income TTM 7.12b / Total Stockholder Equity 84.21b)
RoCE = 5.02% (Ebit 7.76b / (Equity 84.21b + L.T.Debt 70.23b))
RoIC = 3.61% (NOPAT 5.44b / Invested Capital 151.01b)
WACC = 4.62% (E(122.99b)/V(196.82b) * Re(6.93%)) + (D(73.83b)/V(196.82b) * Rd(1.11%) * (1-Tc(0.30)))
Shares Correlation 5-Years: -60.0 | Cagr: -0.15%
Discount Rate = 6.93% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 78.17% ; FCFE base≈11.25b ; Y1≈11.16b ; Y5≈11.64b
Fair Price DCF = 119.2 (DCF Value 206.25b / Shares Outstanding 1.73b; 5y FCF grow -1.57% → 3.0% )
Revenue Correlation: -17.00 | Revenue CAGR: -0.21%
Rev Growth-of-Growth: -3.21
EPS Correlation: 13.72 | EPS CAGR: 6.21%
EPS Growth-of-Growth: 24.98
Additional Sources for BUD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle